- Home
- NSPR vs AVX Comparison
NSPR vs AVX Comparison
Compare NSPR & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSPR | AVX |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | Canada |
| Employees | N/A | 3 |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.5M | 76.4M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | NSPR | AVX |
|---|---|---|
| Price | $1.82 | $0.68 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 36.7K | ★ 403.0K |
| Earning Date | 03-18-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,310,000.00 | N/A |
| Revenue This Year | $65.32 | $530,767.50 |
| Revenue Next Year | $103.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.51 | $0.55 |
| 52 Week High | $2.93 | $2.27 |
Technical Indicators
Market Signals| Indicator | NSPR | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 40.03 |
| Support Level | $1.61 | $0.55 |
| Resistance Level | $2.51 | $0.81 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 50.00 | 6.83 |
Price Performance
Historical ComparisonAbout NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.